Insider Transactions in Q1 2024 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
348
-0.11%
|
$2,436
$7.7 P/Share
|
|
Mar 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
298
-0.06%
|
$2,086
$7.7 P/Share
|
|
Mar 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
765
-0.14%
|
$5,355
$7.7 P/Share
|
|
Mar 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
348
-0.1%
|
$2,436
$7.7 P/Share
|
|
Jan 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,005
-0.58%
|
$18,045
$9.64 P/Share
|
|
Jan 29
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,651
-0.32%
|
$14,859
$9.64 P/Share
|
|
Jan 29
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,929
-0.59%
|
$17,361
$9.64 P/Share
|
|
Jan 29
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
3,178
-0.6%
|
$28,602
$9.64 P/Share
|
|
Jan 16
2024
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+27.91%
|
-
|
|
Jan 16
2024
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
762,360
+49.95%
|
-
|
|
Jan 16
2024
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+36.77%
|
-
|
|
Jan 16
2024
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+37.76%
|
-
|
|
Jan 16
2024
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+35.97%
|
-
|